OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LIFE$6225.0054

MSIG Life Insurance Indonesia Tbk PT

Life & Health InsuranceVerified

The company maintains a strong capital structure with a price-to-book ratio of 1.68 and a debt-to-equity ratio of 0.0, indicating a low leverage position. However, its liquidity position is assessed as medium, with a negative net cash position after accounting for total debt. The company's free cash flow of 90,451,000,000.00 suggests it has the ability to fund operations and potentially return value to shareholders. Profitability metrics show a return on equity of 1.12% and a return on assets of 0.59%, which are below the industry median for life and health insurers. These figures suggest the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is concentrated in Indonesia, with no disclosed international operations. This geographic concentration may expose the company to local economic and regulatory risks. The company does not report segment-specific revenue, making it difficult to assess the contribution of different product lines to overall performance. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The current fiscal year's operating income of 58,593,000,000.00 provides a baseline for future performance. The company's risk assessment indicates a low potential for dilution, which is a positive sign for shareholders. Recent filings and transcripts do not highlight any major events or strategic shifts that would significantly impact the company's operations or financial performance. The company's financial statements remain consistent with prior periods, with no material changes in accounting policies or significant one-time events.

30-day price · LIFE-375.00 (-5.2%)
Low$6525.00High$8300.00Close$6825.00As of13 May, 00:00 UTC
Profile
CompanyMSIG Life Insurance Indonesia Tbk PT
TickerLIFE.JK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. MSIG Life Insurance Indonesia Tbk PT provides life and health insurance products in Indonesia, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. The company is classified under the Financials sector, specifically in the Insurance business sector and the Life & Health Insurance industry, with a confidence level of 0.92.

The company maintains a strong capital structure with a price-to-book ratio of 1.68 and a debt-to-equity ratio of 0.0, indicating a low leverage position. However, its liquidity position is assessed as medium, with a negative net cash position after accounting for total debt. The company's free cash flow of 90,451,000,000.00 suggests it has the ability to fund operations and potentially return value to shareholders. Profitability metrics show a return on equity of 1.12% and a return on assets of 0.59%, which are below the industry median for life and health insurers. These figures suggest the company is underperforming in terms of capital efficiency and asset utilization. The company's revenue is concentrated in Indonesia, with no disclosed international operations. This geographic concentration may expose the company to local economic and regulatory risks. The company does not report segment-specific revenue, making it difficult to assess the contribution of different product lines to overall performance. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The current fiscal year's operating income of 58,593,000,000.00 provides a baseline for future performance. The company's risk assessment indicates a low potential for dilution, which is a positive sign for shareholders. Recent filings and transcripts do not highlight any major events or strategic shifts that would significantly impact the company's operations or financial performance. The company's financial statements remain consistent with prior periods, with no material changes in accounting policies or significant one-time events.
Key takeaways
  • The company has a low debt-to-equity ratio, indicating a conservative capital structure.
  • The company's return on equity and return on assets are below industry medians, suggesting inefficiencies in capital and asset use.
  • The company's liquidity position is medium, with a negative net cash position after accounting for total debt.
  • The company's revenue is concentrated in Indonesia, exposing it to local economic and regulatory risks.
  • The company is not expected to experience significant revenue growth or decline in the next fiscal year.
  • The company has a low potential for dilution, which is favorable for shareholders.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue
Gross profit
Operating income$58.59B
Net income$87.06B
R&D
SG&A
D&A
SBC
Operating cash flow-$345.83B
CapEx-$2.60B
Free cash flow$90.45B
Total assets$14.86T
Total liabilities$7.09T
Total equity$7.77T
Cash & equivalents
Long-term debt$12.63B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$93.86B$73.82B-$418.19B
FY-3$390.84B$367.77B$320.01B
FY-2$50.94B$126.49B-$218.99B
FY-1$369.14B$371.69B$296.77B
FY0$206.23B$206.23B-$149.29B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$16.34T$7.84T
FY-3$15.54T$7.97T
FY-2$14.79T$8.41T
FY-1$14.37T$8.60T
FY0$15.87T$8.70T
PeriodOCFCapExFCFSBC
FY-4$899.83B-$20.49B-$418.19B
FY-3-$1.32T-$11.48B$320.01B
FY-2-$875.05B-$10.96B-$218.99B
FY-1-$603.93B-$16.71B$296.77B
FY0$515.84B-$41.42B-$149.29B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$58.59B$87.06B$90.45B
FQ-6$94.61B$63.93B$38.62B
FQ-5$116.20B$114.45B$113.49B
FQ-4$118.79B$121.62B$116.51B
FQ-3$37.34B$12.54B$14.34B
FQ-2$86.27B
FQ-1$68.65B$68.65B$65.82B
FQ0$30.47B$30.47B$20.29B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$14.86T$7.77T
FQ-6$14.54T$7.65T
FQ-5$14.80T$7.88T
FQ-4$14.37T$8.60T
FQ-3$14.65T$7.83T
FQ-2$15.03T$8.51T
FQ-1$15.15T$8.65T
FQ0$15.87T$8.70T
PeriodOCFCapExFCFSBC
FQ-7-$345.83B-$2.60B$90.45B
FQ-6-$502.35B-$8.53B$38.62B
FQ-5-$677.54B-$10.53B$113.49B
FQ-4-$603.93B-$16.71B$116.51B
FQ-3$34.62B-$4.08B$14.34B
FQ-2$224.16B-$17.25B$86.27B
FQ-1$194.33B-$25.73B$65.82B
FQ0$515.84B-$41.42B$20.29B
Valuation
Market price$6225.00
Market cap$13.07T
Enterprise value$13.09T
P/E150.2
Reported non-GAAP P/E
EV/Revenue
EV/Op income223.3
EV/OCF
P/B1.7
P/Tangible book1.7
Tangible book$7.77T
Net cash-$12.63B
Current ratio
Debt/Equity0.0
ROA0.6%
ROE1.1%
Cash conversion-4.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricLIFEActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity0.0%27.5% medp25 4.7% · p75 66.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 00:57 UTC#fa65cf3e
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 10:26 UTCJob: 0c8f8c8a